Research Use Only: These products are sold for research use only, and are prohibited by law for human or animal consumption.
GLP3-R (Retatrutide) is a laboratory-synthesized peptide compound utilized in controlled research environments to evaluate multi-receptor binding behavior and peptide interaction dynamics. In scientific investigation, it is examined for its structural affinity toward multiple receptor targets and its role in peptide-receptor signaling pathway modeling within experimental assay systems.
Price range: $99.00 through $229.00
Peptides will arrive in a lyophilized (powder) form for maximum stability
GLP-3 RT (LY3437943) is a laboratory-synthesized peptide compound designed for controlled experimental research involving multi-receptor binding analysis. In scientific settings, it is utilized to evaluate peptide interaction behavior with multiple receptor targets and to examine structural and signaling pathway relationships within in-vitro and analytical assay environments.
This compound is supplied exclusively for laboratory and educational research purposes.
In controlled laboratory investigations, GLP-3 RT is examined for:
• Multi-Receptor Binding Modeling — Evaluation of peptide affinity across multiple receptor targets.
• Signal Pathway Mapping — Used to observe receptor-associated signaling behavior in assay systems.
• Peptide Stability Profiling — Studied for resistance to enzymatic degradation under experimental conditions.
• Structure-Function Relationships — Analysis of how molecular modifications influence binding conformation.
• Carrier Protein Interaction — Investigated for albumin-binding behavior in pharmacokinetic modeling systems.
These studies are conducted strictly within non-clinical research environments. No biological outcomes, physiological effects, or therapeutic implications are established.
GLP-3 RT originated from advanced pharmaceutical peptide design research exploring poly-receptor molecular architectures. The compound has been referenced in scientific literature as an example of tri-receptor peptide engineering and multi-agonist structural modeling.
While pharmaceutical derivatives have been evaluated in regulated clinical programs, GLP-3 RT supplied for research use is not an approved drug and is not intended to replicate or replace any proprietary pharmaceutical formulation.
Chemical Classification:
GIP / GLP-1 / Glucagon Receptor Triagonist Reference Compound (LY3437943)
Sequence:
Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂
Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
Molecular Weight: ~4731.3 g/mol
CAS Number: 2381089-83-2
PubChem SID: 171390338
GLP-3 RT is a 39-amino-acid linear peptide incorporating multiple non-coded amino acid substitutions to enhance molecular stability in laboratory assay environments. A C20 fatty diacid moiety is conjugated via a linker segment to facilitate albumin interaction during experimental pharmacokinetic modeling.
These structural features make GLP-3 RT a subject of interest in peptide chemistry, receptor modeling, and molecular interaction research.
GLP-3 RT and related retatrutide structures have been discussed in peer-reviewed publications examining:
• Poly-agonist peptide design principles
• Receptor interaction mapping techniques
• Molecular half-life extension strategies
• Carrier-linked peptide stabilization
• Multi-target binding conformation analysis
Published literature does not establish GLP-3 RT as a therapeutic agent, medical intervention, or approved pharmaceutical compound.
GLP-3 RT is an investigational reference compound supplied strictly for laboratory and educational research. It has not been approved by the FDA or any regulatory authority for diagnostic, therapeutic, preventative, or medical use.
No claims regarding biological benefit, disease modification, or physiological outcome are supported or implied.
This compound is not intended for use in humans or animals.
All products, descriptions, and scientific information provided on this website are intended solely for laboratory, scientific, and educational research. GLP-3 RT is not approved by the FDA and is not intended for human or veterinary use, consumption, injection, therapeutic application, or medical treatment. No content on this website constitutes medical advice, guidance, or endorsement. Any bodily introduction of this compound is strictly prohibited.
• Retatrutide Phase 2 Poly-Agonist Peptide Study
• Multi-Receptor Peptide Engineering Literature
• Structural Modeling of Tri-Agonist Peptides
Products sold by LabGrade Peptides are supplied strictly for laboratory research purposes. They are intended for use by trained professionals in controlled, non-clinical research environments.
No. LabGrade Peptides does not provide usage instructions. Products are supplied for research use only and are intended for professionals familiar with laboratory handling procedures.
Orders are typically processed and shipped within 24 business hours on weekdays. Delivery times vary by location, but most domestic orders arrive within 2–4 business days. Tracking information is provided once the order ships.
Products are supplied in lyophilized form. No additional materials or accessories are included with the product.
By entering this website, you confirm that you are at least 18 years of age and understand that all products are sold strictly for research use only.
Products are designed for laboratory, in vitro, or scientific research purposes and are not intended for human or animal consumption.
